Stay updated with breaking news from Gavin corcoran. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ TrialSpark, a tech-driven drug developer with its own portfolio of clinical stage drug assets, is rebranding to Formation Bio. The new name is. ....
/PRNewswire/ TrialSpark, Inc. announced today that the first patient has been dosed in its Phase 2 clinical trial for ASN008-201, a topical sodium channel. ....
/PRNewswire/ TrialSpark announced today the formation of Libertas Bio following the acquisition of a majority position in a portfolio of immunodermatology. ....
/PRNewswire/ TrialSpark announced today the formation of High Line Bio following the acquisition of worldwide rights to sprifermin from Merck KGaA,. ....
/PRNewswire/ TrialSpark announced today the formation of High Line Bio following the acquisition of worldwide rights to sprifermin from Merck KGaA,. ....